These PI3K/MAPK pathway mutations include NRAS, KRAS, PIK3CA, PTEN, NF1, TSC1 and FGFR3. In two of the three pairs of primary NPC and local recurrence samples, RAS activating mutations were shown to be progression drivers. Here, PIK3CB is linked to nasopharyngeal carcinoma.